Skip to main content
. 2020 Nov 19;103:329–335. doi: 10.1016/j.ijid.2020.11.157

Table 5.

Univariate and multivariable analyses of parameters associated with pneumonia in hospitalised patients with COVID-19.

Parameter Univariate analysis
Multivariable analysis
Pneumonia (n = 57) No pneumonia (n = 497) Odds ratio (95% CI) p-value Adjusted odds ratio (95% CI) p-value
Age >40 years 41 (71.9%) 147 (29.6%) 6.10 (3.32–11.23) <0.001 2.39 (1.01–5.64) 0.047
Asymptomatic illness 4 (7.0%) 62 (12.5%) 0.53 (0.19–1.51) 0.228
Hypertension 15 (26.3%) 38 (7.6%) 4.43 (2.20–8.94) <0.001
Hyperlipidaemia 15 (26.3%) 19 (3.8%) 9.42 (4.35–20.40) <0.001
Diabetes mellitus 7 (12.3%) 14 (2.8%) 4.96 (1.88–13.08) 0.003
Asthma 2 (3.5%) 4 (0.8%) 4.68 (0.83–26.37) 0.113
Prior medical comorbidities 16 (40.0%) 23 (6.3%) 9.94 (4.65–21.27) <0.001 3.92 (1.54–10.00) 0.004
Elevated transaminases 14 (24.6%) 88 (17.7%) 1.51 (0.79–2.89) 0.206
Elevated CRP > 60 mg/L 11 (19.3%) 13 (2.6%) 8.90 (3.78–21.00) <0.001 1.27 (0.32–5.10) 0.785
Elevated LDH > 550 units/L 20 (35.1%) 29 (5.8%) 8.72 (4.51–16.89) <0.001 4.29 (1.71–10.75) 0.002
Elevated ferritin >300 ng/L 13 (22.8%) 36 (7.2%) 3.78 (1.89–7.66) <0.001 2.60 (0.85–7.94) 0.095
Absolute neutrophil count >4 × 109/L 23 (40.4%) 172 (34.6%) 1.28 (0.73–2.24) 0.390
Absolute lymphocyte count <1 × 109/L 22 (38.6%) 66 (13.3%) 4.11 (2.27–7.43) <0.001 2.22 (0.89–5.49) 0.141